Cargando…

Expression of IGF-1, IGF-1 Receptor and Growth Hormone Receptor in Hepatic Tissue in Adults Across the Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

Background: Obesity is a state of relative growth hormone (GH) and insulin-like growth factor-1 (IGF-1) deficiency, and the GH/IGF-1 axis has been implicated in the pathophysiology of nonalcoholic fatty liver disease (NAFLD) and the progression to steatohepatitis (NASH) in preclinical models and hum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dichtel, Laura E, Subudhi, Sonu, Drescher, Hannah, Bartsch, Lea, Osganian, Stephanie, Chicote, Mark, Masia, Ricard, Bredella, Miriam, Bhatia, Sangeeta, Lauer, Georg, Miller, Karen Klahr, Corey, Kathleen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090657/ http://dx.doi.org/10.1210/jendso/bvab048.1097

Ejemplares similares

OR27-2 Growth Hormone Reduces Hepatic Steatosis, Inflammation and Fibrosis in Adults with Overweight/Obesity and Nonalcoholic Fatty Liver Disease
por: Bartsch, Lea, et al.
Publicado: (2022)

MON-286 Peak Stimulated Growth Hormone Is Lower in Subjects with Nonalcoholic Fatty Liver Disease Than Controls of Similar Sex, Age and BMI
por: Dichtel, Laura E, et al.
Publicado: (2020)

PMON53 Resistance to weight gain and obesity in mice lacking the IGF-1 receptor in GHRH neurons
por: Al-Samerria, Sarmed, et al.
Publicado: (2022)

PMON117 IGF-1 Testing: Diagnostic Pitfalls
por: Perez-Martinez, Sebastian
Publicado: (2022)

MON-283 IGF-1 Levels During Normal Pregnancy
por: Thomas, Guillermo Javier, et al.
Publicado: (2020)

MON-298 IGF-1 in the Early Post-operative Assessment of Acromegaly
por: Donegan, Diane, et al.
Publicado: (2020)

ODP319 IGF-1 and BMI are Associated in Obese Patients with Acromegaly
por: Khiyami, Anamil, et al.
Publicado: (2022)

SUN-LB52 The Protective Effects of Hepatocyte GH Receptor (GHR) Signaling Against Steatosis and Liver Injury Is Sexually Dimorphic and Autonomous of IGF1
por: Sarmento-Cabral, Andre, et al.
Publicado: (2020)

Distinct Hepatic Gene‐Expression Patterns of NAFLD in Patients With Obesity
por: Subudhi, Sonu, et al.
Publicado: (2021)

Circulating LEAP-2 Levels in Adult Growth Hormone Deficiency and Their Relationship With IGF-1
por: Vergani, Edoardo, et al.
Publicado: (2021)

PMON61 Evaluation of elevated IGF-1 in patients without clinical evidence of acromegaly
por: Careless, Laura, et al.
Publicado: (2022)

MON-475 Growth Hormone Induces Colon Tissue DNA Damage Independently of IGF-1
por: Chesnokova, Vera, et al.
Publicado: (2019)

The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease
por: Dichtel, Laura E, et al.
Publicado: (2017)

MON-487 Simultaneous Monitoring of 13 IGF-1 Variants in a Clinical Mass Spectrometry Assay
por: Motorykin, Ievgen, et al.
Publicado: (2019)

ODP353 Sustained Suppression of IGF1 with AZP-3813, a Bicyclic 16-Amino Acid Peptide Antagonist of the Human Growth Hormone Receptor and a Potential New Treatment for Acromegaly
por: Culler, Michael, et al.
Publicado: (2022)

THU046 Repeated Treatment With AZP-3813, A Bicyclic, 16-Amino Acid Peptide Antagonist Of The Human Growth Hormone Receptor, Induces Enhanced Suppression Of IGF1 In Beagle Dogs
por: Ravel, Guillaume, et al.
Publicado: (2023)

MON-323 IGF-I Variability and Its Association with Demographic and Clinical Characteristics in Patients with Acromegaly Treated with Injectable Somatostatin Receptor Ligands (SRLS); Results from an International Prospective Phase III Study
por: Samson, Susan Leanne, et al.
Publicado: (2020)

SUN-LB46 Differences in IGF-I Concentrations Between European and US Populations - Consequences for Reference Intervals
por: Bidlingmaier, Martin, et al.
Publicado: (2020)

MON-LB083 The Dimorphic Effects of Short-Term Dietary Changes on the Central and Circulating IGF1 System in Rats
por: Guerra Cantera, Santiago, et al.
Publicado: (2019)

MON-327 Soluble Alpha Klotho and IGF-I Before Surgery as Prognostic Factors to Acromegaly Long-term Remission
por: de Oliveira Longo Schweizer, Junia Ribeiro, et al.
Publicado: (2020)

THU076 GH, IGF-1 And Inflammatory Marker Interactions With Small Bowel Microbial Diversity Are Age And Sex Dependent
por: Leite, Gabriela, et al.
Publicado: (2023)

OR16-6 Cardiometabolic Abnormalities in Patients with Acromegaly with Elevated Plasma IGF-1 Concentrations but GH Concentrations <2ng/ml
por: Hannon, Anne Marie, et al.
Publicado: (2019)

THU075 Sex And Age Specificity Of Correlations Among IGF-1, GH, And Duodenal Microbial Diversity Predicting TMA Biosynthesis
por: Tal, Noa, et al.
Publicado: (2023)

SAT-435 Optimization of Pharmacological Treatment of Acromegaly: Impact on IGF-1 Levels Comparing Isolated Octreotide LAR and Combined Pharmacological Therapy
por: Naves, Luciana, et al.
Publicado: (2019)

MON-271 Identification of IGF-1 Variants in a Clinical Study of 307,000 Specimens: Discrepancies with General Population and Novel Discoveries
por: Motorykin, Ievgen, et al.
Publicado: (2020)

SUN-303 Effects of Open-Label, Adjunctive Ganaxalone Treatment on Resistant Depression in Postmenopausal Women: A Pilot Study
por: Dichtel, Laura E, et al.
Publicado: (2020)

RF13 | PMON59 Tracking and Cumulative Lifetime Exposure to Circulating IGF-I in 6,459 Healthy Individuals and in SGA Children Treated with GH
por: Kjaer, Anna Sophie Lebech, et al.
Publicado: (2022)

FRI293 Phoenixin As A Novel Autocrine/Paracrine Factor Mediating Prolactin Regulation By Functional Interaction Of LH And IGF-I/-II In Carp Pituitary Cells
por: Ye, Cheng, et al.
Publicado: (2023)

MON-319 Impact of Tumor Characteristics and Preoperative IGF-1 Levels on Postoperative Hormonal Remission Following Endoscopic Transsphenoidal Surgery in Patients with Acromegaly: A Single-Surgeon Series
por: Cardinal, Tyler, et al.
Publicado: (2020)

SUN-LB61 Differential and Opposite Regulation of Acid Labile Subunit (ALS) Versus Insulin-Like Growth Factor I (IGF-I) by Oral Estrogens in Premenopausal Women
por: Schilbach, Katharina, et al.
Publicado: (2020)

MON-307 Prospective, Longitudinal Study of Glucose-Suppressed GH Levels in 87 Acromegaly Patients with IGF-1 Normalization After Surgical Therapy: Prognostic Value of Nadir GH Levels for Long-Term Remission or Recurrence
por: Freda, Pamela, et al.
Publicado: (2020)

THU073 Somapacitan Administered Subcutaneously At 5 mg/1.5 mL Or 10 mg/1.5 mL Strengths Yields Clinically Similar PK And IGF-I Profiles In Healthy Participants
por: Rasmussen, Michael Højby, et al.
Publicado: (2023)

LBMON65 Generation Of Serum Insulin Like Growth Factor -1 (IGF-1) Normative Data According To Age, Tanner Staging & Bone Age In Healthy Indian Children And Adolescents With Two Different Assays: The Germinative Study
por: Teja, Ravi, et al.
Publicado: (2022)

Growth Hormone Releasing Hormone Reduces Plasma Markers of Immune Activation and Hepatic Immune Pathways in Nonalcoholic Fatty Liver Disease
por: Stanley, Takara Leah, et al.
Publicado: (2021)

OR0304 Novel Dual Antagonists Of The Growth Hormone Receptor And The Prolactin Receptor
por: Basu, Reetobrata, et al.
Publicado: (2023)

THU048 Determination Of Receptor Binding Affinity Of Growth Hormone Analogues To The Growth Hormone Receptor In A Drug Screening Context
por: Erlendsson, Simon, et al.
Publicado: (2023)

Changes in Quality of Life After Long-Term Biochemical Control of Acromegaly
por: Kimball, Allison, et al.
Publicado: (2021)

FRI296 Somatostatin Receptor 5 Staining In Prolactinomas
por: Mehta, Sonal, et al.
Publicado: (2023)

THU072 Association Between Nonalcoholic Fatty Liver Disease And Growth Hormone Deficiency In Patients With Nonfunctioning Pituitary Adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

RF01 | PMON168 Hedgehog-Induced Somatostatin Receptor Expression is Inhibited by the Activation of the Glucocorticoid Receptor Signaling Pathway in Human Pituitary Adenoma Organoids
por: Zavros, Yana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nfbrt52585fhui1vu90lva93lb